Nhasi, kufutisa kwazova denda repasi rose, uye kuwanda kwekufutisa kwawedzera munyika dzepasi rose.Maererano neWorld Health Organization, zvinofungidzirwa kuti 13 muzana yevanhu vakuru munyika yose vakafuta.Zvinotonyanya kukosha ndezvokuti kufutisa kunogona kukonzeresa metabolic syndrome, iyo inoperekedzwa nematambudziko akasiyana senge Type 2 chirwere cheshuga mellitus, hypertension, nonalcoholic steatohepatitis (NASH), chirwere chemoyo, uye cancer.
Muna Chikumi 2021, iyo FDA yakabvumidza Semaglutide, mushonga wekuderedza uremu wakagadzirwa naNovo Nordisk, saWegovy.Nekuda kwemhedzisiro yayo yakanakisa yekurasikirwa nehuremu, yakanaka yekuchengetedza mbiri uye kusundidzira kubva kune vanozivikanwa vakaita saMusk, Semaglutide yave yakakurumbira pasirese zvekuti zvakatooma kuwana.Sekureva kweNovo Nordisk's 2022 yezvemari, Semaglutide yakagadzira kutengesa kusvika kumadhora gumi nemaviri emadhora muna 2022.
Munguva ichangopfuura, chidzidzo chakabudiswa mu Journal chakaratidza kuti Semaglutide inewo rubatsiro rusingatarisirwi: kudzorera muurayi wechisikigo (NK) cell function mumuviri, kusanganisira kukwanisa kuuraya masero emukenza, izvo zvisingabvi pamushonga wekurema-kurasikirwa nemigumisiro.Ichi chidzidzo zvakare nhau dzakanaka kune varwere vakafuta vachishandisa Semaglutide, vachiratidza kuti mushonga uyu une zvakakosha zvingave zvibatsiro zvekuderedza njodzi yekenza mukuwedzera pakurasikirwa.Chizvarwa chitsva chemishonga, chinomiririrwa neSemaglutide, chiri kushandura kurapwa kwekufutisa uye yakashamisa vaongorori nemhedzisiro yayo ine simba.
Saka, ndiani anogona kuwana uremu hwakanaka kubva mairi?
Kekutanga, boka racho rakakamura vanhu vakafutisa kuita mapoka mana: vaya vanoda kudya zvakanyanya kuti vanzwe vakaguta (nzara yeuropi), vaya vanodya vane uremu hwemazuva ose asi vonzwa nzara gare gare (nzara yomudumbu), vaya vanodya kuti vararame. manzwiro (nzara yepfungwa), uye avo vane zvishoma zvishoma metabolism (slow metabolists).Chikwata ichi chakaona kuti huturu hwevarwere vakafutisa vakapindura zvakanyanya kune iyi mitsva yemishonga yekuderedza uremu nekuda kwezvikonzero zvisingazivikanwe, asi vaongorori vakafunga kuti zvingadaro nekuti mazinga eGLP-1 akange asina kukwira, ndosaka vakawedzera huremu uye, nekudaro, huremu huri nani. kurasikirwa neGLP-1 receptor agonists.
Kufutisa ikozvino kunoonekwa sechirwere chisingaperi, saka mishonga iyi inokurudzirwa kurapwa kwenguva refu.Asi kwenguva yakareba sei?Hazvina kujeka, uye iyi ndiyo nzira yekuongororwa inotevera.
Mukuwedzera, iyi mishonga mitsva yokuderedza uremu yakanga ichishanda zvikuru zvokuti vamwe vatsvakurudzi vakatanga kukurukura kuti uremu hwakarasika hwakadini.Kuderedza uremu hakungodzikisi mafuta chete asiwo kunoita kuti tsandanyama irasikirwe, uye kupera kwetsandanyama kunowedzera njodzi yechirwere chemwoyo, osteoporosis, uye mamwe mamiriro ezvinhu, iyo inonyanya kunetseka kune vakwegura uye avo vane chirwere chemwoyo.Vanhu ava vanobatwa neinonzi obesity fallacy - kuti kurasikirwa nehuremu kunobatanidza nehuwandu hwekufa.
Naizvozvo, mapoka akati wandei akatanga kuongorora yakaderera-dose mhedzisiro yekushandisa aya matsva ekuremesa uremu kugadzirisa matambudziko ane hukama nekufutisa, senge apnea, mafuta ane chiropa chirwere, uye Type 2 chirwere cheshuga, izvo zvisingadi kuti uremu huremerwe.
Nguva yekutumira: Oct-23-2023